ResMed Company

ResMed provides medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnoea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Technology: Wellness and Fitness
Industry: P4 Medicine
Headquarters: United States
Founded Date: 1989
Employees Number: 5001-10000
Funding Status: IPO
Total Funding: $500M
Estimated Revenue: $1B to $10B
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership